Cancer & Cognition

The French platform Cancer and Cognition is the first of its kind dedicated to the study and evaluation of the impact of cancer and its treatments on cognitive functions.

READ MORE

A unique model

A multidisciplinary consortium composed of specialists with comprehensive experience from preclinical testing to the post-cancer period.

OUR ORGANISATION

What is cognition?

Memory, thinking, learning, attention, language…

LEARN MORE

Findings

Cognitive impairment may persist for up to 20 years after chemotherapy.

OUR WORK

We are a multidisciplinary model

expertise-clinique

Clinical

expertise

In clinical trials:  exploring the impact of cancer, treatments and patient care strategies…
.

LEARN MORE

expertise-neuro-psychologique

Neuropsychological

expertise

Focus on cognitive and cerebral damage caused by cancer and cancer treatments

LEARN MORE

expertise-preclinique

Preclinical and biomarkers

expertise

Evaluation and understanding of neurobiological mechanisms and behavioural effects induced by cancer and treatments in animals

LEARN MORE

expertise-biostatistique

Biostatistics

expertise

Study design and implementation, and data analysis

LEARN MORE

photo-témoignage

“ Welcome to the cancer and cognition platform. We aim to provide our expertise on the impact of cancer and its treatments on cognitive functions to oncology intergroups, academic researchers and drug companies. “

Florence JOLY, MD-PhD, Oncologist

When cancer impacts memory

“Chemo fog” is a known condition shared by a number of patients treated with chemotherapy. It is a kind of fog which can alter concentration and be very disabling. Side effects associated with cancer, such as fatigue and memory disorders, are now better taken into account by oncologists. Around 5 min of video.

By the Allodocteurs.fr, 17/02/2011 editorial board

cliquez pour voir la video france 5